pyrrolidine has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Tel, TH; Hersi, F; Omar, HA; Srinivasulu, V; Tarazi, H; Zaher, DM | 1 |
| Darekordi, A; Hassanshahi, G; Mirzaei, MR; Ramezani, M | 1 |
2 other study(ies) available for pyrrolidine and Liver Neoplasms
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Molecular Structure; Pyrrolidines; Structure-Activity Relationship | 2017 |
The New Compound of (2R, 4S)-N-(2, 5-difluorophenyl)-4-Hydroxy-1-(2, 2, 2-Trifluoroacetyl) Pyrrolidine-2-Carboxamide to Mediate the Expression of Some Apoptosis Genes by the HepG2 Cell Line
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrrolidines; Signal Transduction; Tumor Necrosis Factors | 2019 |